8972 Robert Badalament: Diagnosis and treatment of bladder cancer.
Internet, ca. 1995.

C. Der/T. Krontiris/G. Cooper: Transforming genes of human bladder and lung
carcinoma cell lines are homologous to the Ras genes of Harvey and
Kirsten sarcoma viruses. Nature 297 (1982), 3637-...

19899 Pranab Dey: Urinary markers of bladder carcinoma.
Clinica Chimica Acta 340 (2004), 57-65.

M. Goldfarb a.o.: Isolation and preliminary characterization of a human
transforming gene form T24 bladder carcinoma cells.
Nature 296 (1982), 404-...

19903 H. Grossman: I marcatori del cancro della vescica - dalla ricerca alla
clinica. J. Clin. Ligand Ass. (ed. ital.) 26/4 (2003), 190-192.

19891 Lisette Hilton: Urine test boosts detection of recurrent bladder cancer.
Urology Times March 2006, 2p. NMP22 combined with cystoscopy.

19906 Detlef Höwing (ed.): Die Harnblase 2005/1, 16p.

19900 Jacques Irani/Nicolas Mottet/Maria Jose Ribal Caparros/Pierre Teillac:
New trends in bladder cancer management.
Europ. Urol. Suppl. 6 (2007), 388-395.

19892 Giora Katz/Edward Messing: Diagnosis of bladder cancer using a
point-of-care proteomic assay (NMP22 BladderChek) - a multicenter study.
Contemporary Urology August 2006, Supplement, 8p.

18651 Chih-ming Lu/.../Chung-cheng Hsieh: Tea consumption - fluid intake
and bladder cancer risk in Southern Taiwan. Urology 54/5 (1999), 823-828.

19898 Gerson Lüdecke: Früherkennung mit dem NMP22-Test - Hintergrundinterview.
Im Focus Onkologie 2002/6, 26-27.

19905 Gerson Lüdecke: Harnblasenkarzinom, eine unterschätzte Krankheit.
Internet 2007, 6p.

19888 Vincenzo Macchia/Angela Mariano: Marcatori tumorali nel cancro

19889 Matritech: NMP22 bladder chek. Hört genauer hin. Internet ca. 2006, 32.
Eine nützliche Informationsbroschüre.

19895 Matritech: Matritech's NMP22 Bladderchek test. Matritech 2007, 4p.

19901 P. Moonen/L. Kiemeney/J. Witjes: Urinary NMP22 BladderChek test in the
diagnosis of superficial bladder cancer. Europ. Urology 48 (2005), 951-956.

19893 Neil Osterweil/Zalman Agus: Survival drops when bladder cancer surgery
is deferred. Internet 2006, 3p.

19894 Mac Overmyer: Bladder cancer test boosts accuracy of cystoscopy.
Urology Times April 2005, 1p. NMP22.

L. Parada a.o.: Human EJ bladder carcinoma oncogene is homologous of
Harvey sarcoma virus Ras gene. Nature 297 (1982), 474-...

Zbigniew Petrovich/L. Baert/Luther Brady: Carcinoma of the bladder -
innovations in management (medical radiology).
Springer 1997. 3-540-60885-0.

19890 Mark Soloway (ed.): Improving bladder cancer detection - the value
of combining a molecular test with cystoscopy.
Contemp. Urology September 2006, Supplement, 8p.

19902 Robert Svatek/Arthur Sagalowsky/Yair Lotan: Economic impact of screening
for bladder cancer using bladder tumor markers - a decision analysis.
Urologic Oncology Sem. 24 (2006), 338-343.

20776 Raffaele Tenaglia/Giampaolo Bianchi/Gaetano Mobilio (ed.): XVII Congresso
Nazionale Societa' Italiana di Urologia Oncologica.
Arch. Ital. Urol. Androl. 79/3 Suppl.2 (2007), 130p.

19896 Burkhard Ziegler: NMP22 - ein Marker für das Urothelkarzinom.
Internet 2006, 1p.

19897 H. Zuchhold: Blasenkarzinom - einfach im Urin nachweisen mit NMP22.
Internet ca. 2006, 2p.

9073 ZZ: Informationen zum Thema Blasenkrebs.
Öst. Krebshilfe, Internet 1996.

19752 ZZ: Blasenkrebs-Test läßt hoffen. Internet 2005, 2p.
On the tumor marker NMP22.

19904 ZZ: Harnblasenkarzinom. Internet ca. 2006, 3p.

19877 ZZ: Blasenkrebs - Früherkennungsprogramm.
Internet Univ.-Klinik Innsbruck 2007, 4p.